In this study, we investigated the alleviation of atrial fibrosis in AF rats by Wnt3a-targeted (an important member of the Wnt family) regulation of the signaling of Wnt/β-Catenin through miR-27b-3p overexpression, a new molecular mechanism at the miRNA level. The gene discussed is WNT3A; the disease is atrial fibrillation.